Enovis Corporation, an innovation-driven medical technology company, has announced that Oliver Engert has been appointed Chief Administrative Officer, effective today.

In this newly-created role, Oliver will be responsible for leading Enovis’ strategy development, driving organisational efficiency and enhancing operational excellence to support the company in its next phase of profitable, capital-efficient growth.

Damien McDonald, CEO of Enovis, said, “Oliver’s appointment comes at a very exciting time for Enovis. As we take steps to build on our strong foundation and unlock our future potential, his extensive knowledge, skills and expertise are exactly what we need to deliver long-term success. I am excited about the energy, fresh perspective, and external insights he will bring to this role, helping us drive growth and improve efficiency, all to better meet patient needs.”

Oliver spent the last 30 years at McKinsey & Company, where he held progressively senior roles, most recently serving as Senior Partner Emeritus, Special Advisor. During his time there, he supported companies with strategy, transformations, mergers and acquisitions, organisation design, and performance improvement to deliver substantial shareholder value.

Oliver will be primarily based at Enovis’ Lewisville, Texas office. He has a bachelor’s degree in economics from the Wharton School, University of Pennsylvania, and an MBA from the Amos Tuck School of Business, Dartmouth College.